All Providers

Elena Ioana Braicu is a senior gynecologist at the Department for Gynecology Campus Vrchow, Charité Medical University Berlin. She is leading the translational research within this department, and coordinating the Tumor Bank for Ovarian Cancer network (www.toc-network.de).

She qualified in medicine in 2003 from “Iuliu Hatieganu” Medical University in Cluj-Napoca, Romania. She was research fellow at Max Delbrück Research center Berlin in 2003 and 2004, than at the Charité from 2005 and 2006 and at the University of Basel in 2008. Since 2009 she is working at the European Competence Center for Ovarian Cancer at the Charité Medical University.

She is representing the translational group of NOGGO, north eastern German society for gynecological oncology within ENGOT. She is a founding EUTROC member and is leading the working group for biobanking. She is also consultant for pediatric gynecology at the Charité Medical University.

Dr. Braicu participated in several European projects, like OVCAD (www.ovcad.eu) and OCTIPS (www.octips.eu). She is work package leader for biobanking and data repository in the Fp7 European Phase I/II clinical study, Gannet53 (www.gannet53.eu).

She is member in several national and international study groups (e.g. AGO, NOGGO, TOC, ENGOT, EUTROC, GCIG). She is member of the German Foundation of Ovarian Cancer.

Furthermore she is participating in several Phase I to Phase III clinical study as sub-investigator. She is the vice-coordinator of the clinical trial study center at the Charité Medical University.

Since 2013, she is a fellow of the clinical scientist program of the Charité Universitätsmedizin Berlin and the Berlin Institute of Health.

Her main interests are prevention and diagnostic of pelvic tumors in general and high risk population. She is focusing also in the discovery of predictive biomarkers for clinical outcome in ovarian cancer patients.

Christina Fotopoulou trained in obstetrics and gynecology and subspecialized in gynaecological oncology at the Charité University Hospital of Berlin in both the surgical and systemic treatment of women with advanced gynaecological malignancies and completed her PhD thesis entitled “Current Aspects in the Operative Treatment of Epithelial Ovarian Cancer”.

She is currently a Consultant Gynecological Oncologist and Adjunct Professor in the Imperial College London Healthcare Trust in Queen Charlottes Hospital in London and Ovarian Cancer Action Research center.

She has been the leading consultant and Vice Director of the Clinic for Gynecology at the Charité in Berlin, one of the largest reference and accredited centers for gynecological cancer in Germany, as well the Principal Coordinator of the European Competence Center for Ovarian Cancer, which was created in 2007 in Berlin.

Her principal area of clinical practice is in exenterative procedures for advanced forms of pelvic malignancies and in the cytoreductive debulking of primary or relapsed ovarian cancer. Furthermore, she was trained in the reconstructive surgery of oncologic patients after extensive exenterations.

Her area of research is the creation and validation of scores for optimal surgical quality, the analysis of tumour dissemination patterns, histopathological characteristics and surgical outcome in primary and relapsed of ovarian cancer and in the quality of life of patients after extensive operative procedures.

Christina Fotopoulou is a member of the German AGO- Ovarian Cancer Steering Group which is responsible for the generation of national guidelines for the management of ovarian cancer and borderline ovarian lesions. She is the surgical lead in the European Network for Translational Research in Ovarian Cancer (EUTROC) in the working package “Predicting surgical outcome”.

She has broad experience in national and international clinical and surgical trials in Germany and in innovative intraperitoneal immunotherapies in palliative stages of gynaecological malignancies.

She has lectured in many countries on her clinical research and surgical experience.

She is on the editorial board of two journals and reviewer in numerous international gynaecological and oncological journals and is member of various international oncological committees, including ASCO, ESGO, IGCS, ESMO, ENGOT, AGO and NOGGO.

EUTROC (European Translational Research network in Ovarian Cancer) is a European cancer network addressing the fragmentation currently hindering translational research for cutting edge therapies in ovarian cancer.

It will strengthen European excellence in the diagnosis and treatment of OC.

The need to bring promising drug candidates and treatments into clinical settings is currently delayed by the lack of standardised protocols for preclinical animal studies, lack of suitable ovarian cancer models, lack of validated predictive biomarker diagnostics, and integrated appropriate management of translational research partners (including pharma and biotech companies).

Developing effective diagnostic and treatment strategies require structured joint efforts of experts on tumor immunology, epigenetics, pathology, bioinformatics, drug development and delivery, trial development, clinical oncology and gynecological oncology.

Leading European researchers and clinicians together with the pharmaceutical industry and biotech companies will focus on preclinical and clinical studies in ovarian cancer. Therefore new targets will be identified, validated and translated to new drugs and brought to clinical practice. Standardisation and harmonisation of laboratory practices and good clinical practice procedures will BE performed within the consortium.

The consortium combines expertise in clinical as well as preclinical research. Involved researchers are coordinating a number of investigator-initiated Phase I, II trials.The Network will build a platform for research and strong educational programs for the next generation of experts aimed at developing individualised patients benefit.

Dr. Alessandro Giardini is a consultant paediatric cardiologist at Great ormond Street Hospital in London and specializes in the diagnosis and care of babies, children and adolescents with congenital heart disease.

Personal website  at: www.childheartspecialist.com

After qualifying as a doctor from the University of Malta in 2004 and completing her housemanship on the island, Dr. Raina Zarb Adami then moved to Sydney, where she gained post-graduate experience in general and plastic surgery. She became a member of the Royal College of Surgeons of Edinburgh in 2008.

Dr. Zarb Adami’s approach to non-invasive facial rejuvenation and sculpting is unrivalled. She brings passion for quality to a cosmetic practice where integrity, intelligence and striving for perfection flourish. Her artistic eye complements a thorough scientific and surgical expertise.

She is an advanced practitioner based in London with an integrated approach using Botox (Botulinum Toxin), dermal fillers for treatments like lip enhancement and non-surgical rhinoplasty, skin care, chemical peels and Dermaroller microneedling techniques for facial rejuvenation and enhancement.

Her background in plastic surgery allows Dr. Zarb Adami to provide mole removal, scar treatment and split earlobe repair, offering optimal cosmetic outcomes.

Dr. Zarb Adami continues to attend and present at numerous conferences and workshops in aesthetic medicine and plastic surgery, both nationally and internationally. She has been awarded The Professions Woman of the Future in The Woman of the Future Awards 2010 and the Rising Star Award at the Aesthetic Awards UK 2011-2012.

She has successfully trained many practitioners in cosmetic procedures, and is a certified lecturer on the subject through The Academy of Aesthetic Excellence based in London. Dr Zarb Adami has dedicated time to volunteering with an Australian plastic surgery team operating on victims of burn injuries in Nepal. She also regularly participates in various other international voluntary work projects.

She is currently undertaking a research project as a PhD with the charity organisation RAFT (Restoration of Appearance and Function Trust) to develop an artificial skin – the Smart Matrix – to treat patients suffering from burns and other chronic and complex wounds.

Niroshan Sivathasan completed his bachelor’s and medical degrees at the age of 23 from King’s College London and University College London, respectively.

His postgraduate qualifications in surgery and aesthetic medicine were also gained in London. He has published over 30 articles, and is a reviewer and editorial committee-member for various medical journals.

He has a particular interest in cosmesis, and is undertaking an international fellowship in cosmetic surgery.

Dr. Sanjay Rao is a Pediatric Surgeon from Bangalore working at Narayana Hrudayalaya Hospital, Bangalore.

He pursued his MBBS from Jawaharlal Nehru Medical College, Belgaum. He is highly qualified, with an MS in General Surgery, DNB in General Surgery, M.Ch in Pediatric Surgery and DNB in Pediatric Surgery.

Dr. Sanjay Rao has won many accolades for being the topper in various medical examinations. He has also won the Late Shri MC Valayutham prize for Anatomy, an award for Pharmacology, Community Medicine and so on.

As a dedicated medical practitioner, Dr. Sanjay has had a wide range of experience working in General Surgery as well as Pediatric Surgery. He has held many prestigious posts and has worked as the house officer in LTMG Hospital, Bombay, Registrar in MW Desai Hospital, Mumbai, Lecturer at LTMG Hospital, Specialist Registrar at Glasgow, UK etc.

Dr. Sanjay is also a member of many associations like the Association of Surgeons in India, National Academy of Medical Sciences, and British Association of Pediatric Surgeons. He has several research papers and publications to his credit.

Dr. Sanjay is also a keen participant in seminars and conferences conducted around the world. He has attended many workshops on Perinatology and Pediatric Surgeries, and his scientific papers has also been well received. Apart from this, he has also contributed his ideas in various medical books.

Dr. Jacob Varghese is a Critical Care Specialist at Narayna Hrudayalaya in Bangalore, India.

Prof. Ramesh Tripathi is currently the Clinical Director of Narayana Institute of Vascular Sciences at Narayana Hrudayalaya Health City, Bangalore, India.

His experience as a Consultant Vascular Surgeon spans over 19 years during which he has performed in excess of 9000 Vascular, 7000 endovascular procedures and 1400 Endovenous Laser treatments of varicose veins.

He has trained, worked, collaborated and tutored at leading Universities and hospitals internationally including USA, UK, Germany, India, Australia and New Zealand. He is credited for performing India’s first Endovascular repair of Abdominal Aortic Aneurysm in 1997 followed by India’s first Thoracic Aortic Aneurysm repair in 1998.

He also performed the first Implant of Medtronic Xcelerant AAA stent graft in Australia and New Zealand at Wellington Hospital, New Zealand on June 2005. He has since then performed over 900 Endovascular and hybrid repairs of Thoracic and Abdominal Aortic Aneurysms.

He is the first Vascular Surgeon from India to be honored as a Distinguished Fellow of Society of Vascular Surgery. He is an internationally renowned leading opinion maker in Vascular and Endovascular Surgery, who has made significant pioneering contributions to innovative, minimally invasive and new advances in Endovascular Surgery especially in the areas of Treatment of Thoracic and Abdominal Aortic Aneurysms for his innovative experimental work on in-situ fenestration of thoracic stent-grafts and Deep Venous Valve Surgery.

He is a Faculty and Speaker at many international Vascular Conferences for numerous years including VEITH Symposium, Charing Cross Symposium, European Vascular Course, ISET, American Venous Forum, Aristotle Vascular Experts’ Meeting, Australian and New Zealand Society of Vascular Surgery, Asian Society of Vascular Surgery, Sicilian Vascular Symposium, Aorta Italy, CICE Brazil, International Congress of Endovascular Interventions Arizona, New Zealand Society of Vascular Surgery and Vascular Society of India.

In India, his research interests revolve around endovascular treatments and genetics of Aortic Aneurysms, bioabsorbable Polymer stents and biology of leg ulceration. He is the Editor in Chief of Indian Journal of Vascular Surgery and a member of the editorial boards of Phlebology, Vascular Disease Management, AORTA and Venous Forum of American College of Phlebology. He reviews publications for 9 Journals.

Dr. Balakrishna Naik , MBBS, MD, D.G.O,Senior Consultant,Obstetrician and Gynecologist at NH Multispecialty Hospital, Bangalore,India.